Active — Not RecruitingNot Applicable

Hemodynamic Parameters in People With Atherosclerotic Vascular Disease Referred to a Secondary Prevention and Cardiovascular Rehabilitation Program

Canada80 participantsStarted 2024-11-25

Plain-language summary

The main purpose of this study is to evaluate the hemodynamic changes in the forefoot of patients with coronary, cerebrovascular or peripheral atherosclerotic disease referred a 12-week cardiovascular rehabilitation program (PREV program). Also, this study will describe the characteristics of patients admitted to the PREV program and their evolutions in terms of favorable, unfavorable outcomes and complications and up to one year after completion of the program.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Any individual aged 18 years and older who has been diagnosed with peripheral artery disease, coronary artery disease, angina, ischemic heart failure, transient ischemic attack or ischemic stroke (non-cardioembolic, non-hemorrhagic); * Have been admitted to the PREV program; Exclusion Criteria: * Being not able to give written informed consent;

What they're measuring

Change in toe pressure measurement

Timeframe: Change from baseline to 12 weeks

Change in the toe-brachial index

Timeframe: Change from baseline to 12 weeks

Change in the ankle-brachial index

Timeframe: Change from baseline to 12 weeks

Trial details

NCT IDNCT06701032

SponsorLaval University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08-29

View on ClinicalTrials.gov More Peripheral Artery Disease (PAD) trials